The transdermal drug delivery devices market is estimated to represent a global market of USD 32.56 billion by 2016 with growth rate of 8.9%. Skin comprises of three distinct however internally dependent tissues. The layer has been categorized into vascular, stratified, and cellular epidermis. Over the past few decades, controlled drug delivery has become widely important across the pharma industry. This is the reason; transdermal drug delivery devices market is seen upward trend over the past few years. Due to technological advancements, which improve the drug absorption ability through the skin pores without rupturing the skin tissues, transdermal drug delivery has become widely accepted route of drug administration among the companies. It is being justified by the fact that in last few years, approximately 35 transdermal products are approved by the U.S. FDA. Transdermal drug delivery system is defined as the administration of the drugs through skin for the systemic circulation at a predetermined rate of time. The industry is growing constantly and currently represent around 12% of the global drug delivery system market. Benefits of this drug delivery systems are considered to be the primary driving factor for the market growth. For example, transdermal drug delivery offers effective use of therapeutics with short biological half-life, allow drug administration with narrow therapeutics window, and avoid drug degradation in acidic medium.

Download  Sample of This Strategic

Additionally, many large or small scale companies are actively engaged in developing novel transdermal products which will drive the market growth to great extent. For example, in December 2015, 4P Therapeutics LLC demonstrated the preclinical, proof of mechanism for the Transdermal Follicle Stimulating Hormone delivery patch in infertility treatment. This demonstration was done to exhibit the preclinical efficacy of this system in reducing patient pain and thus improving patient compliance. Such initiatives will increase the product penetration hence drives the market growth. However, large molecular size therapeutics are not recommended to administer through this delivery system owing to its potential side effects, leading to hamper the market growth to some extent.

The market is primarily categorized into two categories such as technology and application. In terms of technology, the market is analyzed as Thermal, Mechanical arrays, Ultrasound, Microporation, Electroporation, Iontophoresis, and Others. Iontophoresis segment is accounted for the largest share of the global market, captured 17.23% share of the market in 2016. High efficiency coupled with ability of this technique to administer wide range of particles drive segment growth. These drug molecules primarily include insulin, hormones, proteins, and peptides. In its ability to deliver anionic, cationic, and hydrophilic drugs, is also responsible for the significant revenue of this segment.

The market, by application is divided into CNS, Pain Management, Hormone and Others. Among different application area, pain management is considered to be the largest revenue generating segment, accounted for more than 5.1 billion in 2016. Availability of wide range of therapeutics that can be used for transdermal delivery for pain treatment helped this segment to augment the market growth.

Companies such as Novartis, Johnson & Johnson, Mylan, Boehringer Ingelheim, Biogel Technologies Inc., and Transdermal Technologies Inc. are operating in this market. Strategic merger and acquisitions and rising research and development acitivities to introduce new delivery system is considered to be the primary strategies of companies to expand their market share.

Request For Full

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

Historical Year – 2014 & 2015

Base Year – 2015

Estimated Year – 2016

Projected Year – 2025


Traders, Distributors, And Suppliers



Government and Regional Agencies and Research Organizations




The scope of this report covers the market by its major segments, which include as follows:



Mechanical arrays








Pain Management




North America


Asia Pacific

Rest of the World


Further Breakdown of The North America Market



Further Breakdown of The Europe Market



Rest of Europe

Further Breakdown of The APAC Market



Rest of APAC

Further Breakdown of The Rest of the World Market

Middle East and Africa

Latin America

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Name: Kenneth research

Email:[email protected]

Phone: +1 313 462 0609

<<<<<<New Trending Report>>>>>>

Reprocessed Medical Devices Market
Intravenous Immunoglobulin Market
Spinal Pumps Market
Molecule Diagnostics Market

Source link